Sipke Dijkstra

776 total citations
16 papers, 456 citations indexed

About

Sipke Dijkstra is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Sipke Dijkstra has authored 16 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Sipke Dijkstra's work include Nerve injury and regeneration (5 papers), Genetic Neurodegenerative Diseases (4 papers) and Spinal Cord Injury Research (4 papers). Sipke Dijkstra is often cited by papers focused on Nerve injury and regeneration (5 papers), Genetic Neurodegenerative Diseases (4 papers) and Spinal Cord Injury Research (4 papers). Sipke Dijkstra collaborates with scholars based in Netherlands, United States and Germany. Sipke Dijkstra's co-authors include Elbert A.J. Joosten, Eldon E. Geisert, P.R. Bär, David F. Fischer, W.H. Gispen, C Dijkstra, Matthew Gardener, Hans S. Keirstead, John H. Weiss and Aleksandra J. Poole and has published in prestigious journals such as PLoS ONE, The Journal of Comparative Neurology and Scientific Reports.

In The Last Decade

Sipke Dijkstra

16 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sipke Dijkstra Netherlands 12 230 194 83 80 78 16 456
Hana Friedman Canada 12 208 0.9× 250 1.3× 74 0.9× 25 0.3× 146 1.9× 20 493
Philip C. Buttery United Kingdom 12 273 1.2× 330 1.7× 78 0.9× 37 0.5× 222 2.8× 17 666
Karen Gorse United States 14 120 0.5× 353 1.8× 57 0.7× 28 0.3× 57 0.7× 21 633
Ramesh Menon Italy 10 170 0.7× 371 1.9× 137 1.7× 48 0.6× 131 1.7× 11 605
G. Michailov Germany 5 491 2.1× 266 1.4× 64 0.8× 37 0.5× 278 3.6× 7 784
Jian-Min Luo China 10 232 1.0× 195 1.0× 66 0.8× 23 0.3× 118 1.5× 23 481
Véronique Menet France 5 304 1.3× 187 1.0× 124 1.5× 122 1.5× 206 2.6× 5 517
Linda A. White United States 10 361 1.6× 223 1.1× 50 0.6× 64 0.8× 244 3.1× 12 561
Yatma Gueye France 9 118 0.5× 170 0.9× 52 0.6× 65 0.8× 47 0.6× 10 412
Massimiliano Cristofanilli United States 12 135 0.6× 164 0.8× 40 0.5× 54 0.7× 117 1.5× 14 355

Countries citing papers authored by Sipke Dijkstra

Since Specialization
Citations

This map shows the geographic impact of Sipke Dijkstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sipke Dijkstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sipke Dijkstra more than expected).

Fields of papers citing papers by Sipke Dijkstra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sipke Dijkstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sipke Dijkstra. The network helps show where Sipke Dijkstra may publish in the future.

Co-authorship network of co-authors of Sipke Dijkstra

This figure shows the co-authorship network connecting the top 25 collaborators of Sipke Dijkstra. A scholar is included among the top collaborators of Sipke Dijkstra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sipke Dijkstra. Sipke Dijkstra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Fischer, David F., Sipke Dijkstra, Johnny Suijker, et al.. (2022). Development of mAb-based polyglutamine-dependent and polyglutamine length-independent huntingtin quantification assays with cross-site validation. PLoS ONE. 17(4). e0266812–e0266812. 3 indexed citations
2.
Miller, James R. C., Edith L. Pfister, Wanzhao Liu, et al.. (2017). Allele-Selective Suppression of Mutant Huntingtin in Primary Human Blood Cells. Scientific Reports. 7(1). 46740–46740. 18 indexed citations
3.
Macdonald, Douglas, Michela Tessari, Melanie Smith, et al.. (2014). Quantification Assays for Total and Polyglutamine-Expanded Huntingtin Proteins. PLoS ONE. 9(5). e96854–e96854. 41 indexed citations
4.
Todd, Daniel G., Simon DOWLER, Michael D. Wall, et al.. (2014). A Monoclonal Antibody TrkB Receptor Agonist as a Potential Therapeutic for Huntington’s Disease. PLoS ONE. 9(2). e87923–e87923. 70 indexed citations
5.
Schenk, Geert J., Sipke Dijkstra, Susanne M. A. van der Pol, et al.. (2013). Roles for HB‐EGF and CD9 in multiple sclerosis. Glia. 61(11). 1890–1905. 23 indexed citations
6.
Rossi, Sharyn L., Gabriel Nistor, Hong Yin, et al.. (2010). Histological and Functional Benefit Following Transplantation of Motor Neuron Progenitors to the Injured Rat Spinal Cord. PLoS ONE. 5(7). e11852–e11852. 79 indexed citations
7.
Dijkstra, Sipke, Gijs Kooij, P. Richard Verbeek, et al.. (2008). Targeting the tetraspanin CD81 blocks monocyte transmigration and ameliorates EAE. Neurobiology of Disease. 31(3). 413–421. 26 indexed citations
8.
Dijkstra, Sipke, Simone Duis, Alex J. Lankhorst, et al.. (2006). Intraspinal administration of an antibody against CD81 enhances functional recovery and tissue sparing after experimental spinal cord injury. Experimental Neurology. 202(1). 57–66. 19 indexed citations
9.
Lund, Søren Peter, Peter Pörzgen, Henrik Hasseldam, et al.. (2005). Inhibition of microglial inflammation by the MLK inhibitor CEP‐1347. Journal of Neurochemistry. 92(6). 1439–1451. 57 indexed citations
10.
Dijkstra, Sipke, Eldon E. Geisert, C Dijkstra, P.R. Bär, & Elbert A.J. Joosten. (2001). CD81 and microglial activation in vitro: proliferation, phagocytosis and nitric oxide production. Journal of Neuroimmunology. 114(1-2). 151–159. 29 indexed citations
11.
Joosten, Elbert A.J., et al.. (2000). Collagen IV deposits do not prevent regrowing axons from penetrating the lesion site in spinal cord injury. Journal of Neuroscience Research. 62(5). 686–691. 21 indexed citations
12.
Dijkstra, Sipke, et al.. (2000). Up-regulation of CD81 (target of the antiproliferative antibody; TAPA) by reactive microglia and astrocytes after spinal cord injury in the rat. The Journal of Comparative Neurology. 428(2). 266–277. 33 indexed citations
13.
Joosten, Elbert A.J., Sipke Dijkstra, Gary A. Brook, Henk Veldman, & P.R. Bär. (2000). Collagen IV deposits do not prevent regrowing axons from penetrating the lesion site in spinal cord injury. Journal of Neuroscience Research. 62(5). 686–691. 2 indexed citations
14.
Dijkstra, Sipke, P.R. Bär, W.H. Gispen, & Elbert A.J. Joosten. (1999). Selective stimulation of dendrite outgrowth from identified corticospinal neurons by homotopic astrocytes. Neuroscience. 92(4). 1331–1342. 27 indexed citations
15.
Kaal, Evert C. A., et al.. (1999). Experimental models for ALS - a short review. Neuroscience Research Communications. 25(1). 1–11. 6 indexed citations
16.
Dijkstra, Sipke, et al.. (1969). Maximum conduction velocity and range of conduction velocity in motor fibers of the deep peroneal nerve in patients with chronic renal insufficiency. Electroencephalography and Clinical Neurophysiology. 27(7). 715–715. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026